Zentalis Pharmaceuticals (ZNTL) Stock Chart & Stock Price History $1.64 -0.04 (-2.08%) As of 01:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Zentalis Pharmaceuticals Stock Price Performance The Zentalis Pharmaceuticals (ZNTL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 44.98%, with a year-to-date return of -45.71%. In the past month, the stock has increased 10.40%, reflecting recent market activity. As of the latest close, Zentalis Pharmaceuticals traded at $1.68 with a market cap of $121.19 million and volume of 655,807 shares. Five years ago, the stock traded at $40.91, representing a 95.98% decrease over that period. At the time, it had a market cap of $1.64 billion and a volume of 65,744 shares. Receive ZNTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zentalis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.30%1 Month Performance+10.40%3 Month Performance+23.68%Year-To-Date Performance-45.71%1 Year Performance-44.98%5 Year Performance-95.98% ZNTL Stock Chart for Monday, October, 13, 2025 ZNTL Chart by TradingView Zentalis Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/10/2025$1.81$1.68-7.18%$1.84$1.67655,807 shs$121.19 million10/09/2025$1.64$1.81+10.37%$1.83$1.65985,653 shs$130.57 million10/08/2025$1.55$1.64+5.81%$1.68$1.57572,938 shs$118.31 million10/07/2025$1.59$1.55-2.52%$1.61$1.531.01 million shs$111.81 million10/06/2025$1.61$1.59-1.24%$1.68$1.58441,253 shs$114.70 million10/03/2025$1.66$1.61-3.01%$1.69$1.60739,723 shs$116.15 million10/02/2025$1.54$1.66+7.79%$1.67$1.54458,681 shs$119.75 million10/01/2025$1.51$1.54+1.99%$1.57$1.51416,030 shs$111.09 million09/30/2025$1.49$1.51+1.34%$1.59$1.47505,432 shs$108.93 million09/29/2025$1.55$1.49-3.87%$1.58$1.471.20 million shs$107.49 million Get the Latest News and Ratings for ZNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zentalis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/26/2025$1.49$1.55+4.03%$1.59$1.49898,819 shs$111.82 million09/25/2025$1.52$1.49-1.97%$1.56$1.49526,437 shs$107.48 million09/24/2025$1.50$1.52+1.33%$1.65$1.501.46 million shs$109.65 million09/23/2025$1.52$1.50-1.32%$1.54$1.46323,251 shs$108.21 million09/22/2025$1.52$1.52$1.57$1.49353,659 shs$109.65 million09/19/2025$1.49$1.52+2.01%$1.57$1.471.07 million shs$109.65 million09/18/2025$1.42$1.49+4.93%$1.52$1.41533,661 shs$107.49 million09/17/2025$1.42$1.42$1.50$1.41550,469 shs$102.44 million09/16/2025$1.45$1.42-2.07%$1.46$1.40594,533 shs$102.43 million09/15/2025$1.49$1.45-2.68%$1.50$1.41745,409 shs$104.60 million09/12/2025$1.56$1.49-4.49%$1.58$1.49505,455 shs$107.49 million Related Companies PRTC Stock Chart SLDB Stock Chart ADCT Stock Chart UPXI Stock Chart KRRO Stock Chart AUTL Stock Chart ATXS Stock Chart EOLS Stock Chart ALMS Stock Chart ETHZ Stock Chart Receive ZNTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Zentalis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZNTL) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zentalis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zentalis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
